SCHEMBL4916258

SCHEMBL4916258

Cc1cccc(CNC(=O)N2CCC(CCCC(=O)NO)CC2)c1

nearest known ligand 0.77

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 12/20 0.77
HDAC6 Q9UBN7 12/20 0.77
HDAC3 O15379 11/20 0.77
HDAC4 P56524 11/20 0.77
HDAC7 Q8WUI4 11/20 0.77
HDAC2 Q92769 11/20 0.77
HDAC10 Q969S8 11/20 0.77
HDAC11 Q96DB2 11/20 0.77
HDAC8 Q9BY41 11/20 0.77
HDAC9 Q9UKV0 11/20 0.77
HDAC5 Q9UQL6 11/20 0.77
CTDSP1 Q9GZU7 1/20 0.52
TDP1 Q9NUW8 1/20 0.52
MEN1 O00255 2/20 0.49
KMT2A Q03164 2/20 0.49
FAAH O00519 2/20 0.47
LMNA P02545 1/20 0.44
POLB P06746 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4929026 0.88 HDAC1 (0.77) HDAC1HDAC6HDAC3HDAC4HDAC7
SCHEMBL4926584 0.88 HDAC3 (0.77) HDAC1HDAC6HDAC3HDAC4HDAC7
SCHEMBL4926485 0.87 HDAC3 (0.79) HDAC1HDAC6HDAC3HDAC4HDAC7
SCHEMBL4916650 0.87 HDAC1 (0.72) HDAC1HDAC6HDAC3HDAC4HDAC7
SCHEMBL4926463 0.87 HDAC3 (1.00) HDAC1HDAC6HDAC3HDAC4HDAC7
SCHEMBL4925628 0.87 HDAC1 (0.82) HDAC1HDAC6HDAC3HDAC4HDAC7
SCHEMBL5174817 0.83 HDAC1 (0.61) HDAC1HDAC6HDAC3HDAC4HDAC7
SCHEMBL4927435 0.83 HDAC3 (0.76) HDAC1HDAC6HDAC3HDAC4HDAC7
SCHEMBL4923890 0.81 HDAC1 (0.72) HDAC1HDAC6HDAC3HDAC4HDAC7
SCHEMBL4930468 0.81 HDAC3 (0.54) HDAC1HDAC6HDAC3HDAC4HDAC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080207694-A1 Hydroxamates as Histone Deacetylase Inhibitors and Pharmaceutical Formulations Containing Them ROSSI CRISTINA 2008-08-28 US claimed
US-20080207694-A1 Hydroxamates as Histone Deacetylase Inhibitors and Pharmaceutical Formulations Containing Them ROSSI CRISTINA 2008-08-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080207694-A1 Hydroxamates as Histone Deacetylase Inhibitors and Pharmaceutical Formulations Containing Them HDAC1, HDAC8, HDAC9 HDAC1 1/4885HDAC6 11/4885HDAC3 8/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.